International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that Co-Chairman of the Board and Chief Executive Officer Andrey Semechkin PhD has published an open letter to shareholders. The letter provides an update on how the Company intends to increase its visibility, recognition and market capitalization and an outline of the most significant near term objectives.
http://ift.tt/1umGaB8
http://ift.tt/1umGaB8
No comments:
Post a Comment